Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
PURPOSE: Ibuprofen is the drug of choice for treatment of patent ductus arteriosus (PDA). There is accumulating evidence that current ibuprofen-dosing regimens for PDA treatment are inadequate. We aimed to propose an improved dosing regimen, based on all current knowledge. METHODS: We performed a li...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244763/ https://www.ncbi.nlm.nih.gov/pubmed/30054639 http://dx.doi.org/10.1007/s00228-018-2529-y |
_version_ | 1783372114135351296 |
---|---|
author | Flint, Robert B. ter Heine, Rob Spaans, Edwin Burger, David M. de Klerk, Johan C. A. Allegaert, Karel Knibbe, Catherijne A. J. Simons, Sinno H. P. |
author_facet | Flint, Robert B. ter Heine, Rob Spaans, Edwin Burger, David M. de Klerk, Johan C. A. Allegaert, Karel Knibbe, Catherijne A. J. Simons, Sinno H. P. |
author_sort | Flint, Robert B. |
collection | PubMed |
description | PURPOSE: Ibuprofen is the drug of choice for treatment of patent ductus arteriosus (PDA). There is accumulating evidence that current ibuprofen-dosing regimens for PDA treatment are inadequate. We aimed to propose an improved dosing regimen, based on all current knowledge. METHODS: We performed a literature search on the clinical pharmacology and effectiveness of ibuprofen. (R)- and (S)-ibuprofen plasma concentration-time profiles of different dosing regimens were simulated using a population pharmacokinetic model and evaluated to obtain a safe, yet likely more efficacious ibuprofen exposure. RESULTS: The most effective intravenous ibuprofen dosing in previous clinical trials included a first dose of 20 mg kg(−1) followed by 10 mg kg(−1) every 24 h. Simulations of this dosing regimen show an (S)-ibuprofen trough concentration of 43 mg L(−1) is reached at 48 h, which we assumed the target through concentration. We show that this target can be reached with a first dose of 18 mg kg(−1), followed by 4 mg kg(−1) every 12 h. After 96 h postnatal age, the dose should be increased to 5 mg kg(−1) every 12 h due to maturation of clearance. This twice-daily dosing has the advantage over once-daily dosing that an effective trough level may be maintained, while peak concentrations are substantially (22%) lower. CONCLUSIONS: We propose to improve intermittent ibuprofen-dosing regimens by starting with a high first dose followed by a twice-daily maintenance dosing regimen that requires increase over time and should be continued until sufficient effect has been achieved. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00228-018-2529-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6244763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-62447632018-12-04 Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns Flint, Robert B. ter Heine, Rob Spaans, Edwin Burger, David M. de Klerk, Johan C. A. Allegaert, Karel Knibbe, Catherijne A. J. Simons, Sinno H. P. Eur J Clin Pharmacol Pharmacokinetics and Disposition PURPOSE: Ibuprofen is the drug of choice for treatment of patent ductus arteriosus (PDA). There is accumulating evidence that current ibuprofen-dosing regimens for PDA treatment are inadequate. We aimed to propose an improved dosing regimen, based on all current knowledge. METHODS: We performed a literature search on the clinical pharmacology and effectiveness of ibuprofen. (R)- and (S)-ibuprofen plasma concentration-time profiles of different dosing regimens were simulated using a population pharmacokinetic model and evaluated to obtain a safe, yet likely more efficacious ibuprofen exposure. RESULTS: The most effective intravenous ibuprofen dosing in previous clinical trials included a first dose of 20 mg kg(−1) followed by 10 mg kg(−1) every 24 h. Simulations of this dosing regimen show an (S)-ibuprofen trough concentration of 43 mg L(−1) is reached at 48 h, which we assumed the target through concentration. We show that this target can be reached with a first dose of 18 mg kg(−1), followed by 4 mg kg(−1) every 12 h. After 96 h postnatal age, the dose should be increased to 5 mg kg(−1) every 12 h due to maturation of clearance. This twice-daily dosing has the advantage over once-daily dosing that an effective trough level may be maintained, while peak concentrations are substantially (22%) lower. CONCLUSIONS: We propose to improve intermittent ibuprofen-dosing regimens by starting with a high first dose followed by a twice-daily maintenance dosing regimen that requires increase over time and should be continued until sufficient effect has been achieved. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00228-018-2529-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-07-28 2018 /pmc/articles/PMC6244763/ /pubmed/30054639 http://dx.doi.org/10.1007/s00228-018-2529-y Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Pharmacokinetics and Disposition Flint, Robert B. ter Heine, Rob Spaans, Edwin Burger, David M. de Klerk, Johan C. A. Allegaert, Karel Knibbe, Catherijne A. J. Simons, Sinno H. P. Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title | Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title_full | Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title_fullStr | Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title_full_unstemmed | Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title_short | Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
title_sort | simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns |
topic | Pharmacokinetics and Disposition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244763/ https://www.ncbi.nlm.nih.gov/pubmed/30054639 http://dx.doi.org/10.1007/s00228-018-2529-y |
work_keys_str_mv | AT flintrobertb simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT terheinerob simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT spaansedwin simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT burgerdavidm simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT deklerkjohanca simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT allegaertkarel simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT knibbecatherijneaj simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns AT simonssinnohp simulationbasedsuggestionstoimproveibuprofendosingforpatentductusarteriosusinpretermnewborns |